Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AMPA receptor is a subtype of ionotropic glutamate receptors that mediates fast excitatory synaptic transmission in the central nervous system. It is a tetrameric ion channel composed of GluA1-4 subunits and is crucial for rapid neuronal communication, learning, memory, and synaptic plasticity. Upon glutamate binding, the channel opens, allowing Na+ influx and neuronal depolarization. Auxiliary proteins modulate its trafficking, gating, and pharmacology. The defining agonist is AMPA itself.
Agonists bind to the ligand-binding domain of the AMPA receptor, causing a conformational change that opens the ion channel pore, allowing influx of Na+ (and Ca2+ in some cases) and subsequent neuronal depolarization.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPA Receptor).